Low patient satisfaction in psoriasis and psoriatic arthritis for clinicians and treatment is tied to need for better ...
Enlivex (ENLV) has released an update. Enlivex Therapeutics has announced the successful dosing of the first patient in a Phase I trial to test ...
Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...
MoonLake Immunotherapeutics (MLTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.
Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.